Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1463258
This article is part of the Research Topic Immunological Precision Therapeutics: Integrating Multi-Omics Technologies and Comprehensive Approaches for Personalized Immune Intervention View all 18 articles

Prognostic value of EMT-related genes and immune cell infiltration in Thyroid Carcinoma

Provisionally accepted
Shuping Wu Shuping Wu 1Yu Liu Yu Liu 2Yu Zeng Yu Zeng 2Xianhui Ruan Xianhui Ruan 2Mei Tao Mei Tao 2Wenrong Lin Wenrong Lin 3*Chang Liu Chang Liu 1*Hongbin Chen Hongbin Chen 1Hui Liu Hui Liu 1*Yu Wu Yu Wu 1*
  • 1 Department of Head and Neck Surgery, Clinical Oncology School of Fujian Medical University & Fujian Cancer Hospital, Fuzhou, China
  • 2 Department of Thyroid and Neck Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
  • 3 Department of Ultrasound, Clinical Oncology School of Fujian Medical University, Fuzhou, China

The final, formatted version of the article will be published soon.

    Background:The EMT is a very important process involved in cancer invasion and metastasis. Additionally, CTSK gene is closely related to the degradation of the extracellular matrix, which is a critical component of the EMT. The purpose of this study was to determine the relationships between EMT-related genes and immune cell infiltration and their prognostic value in Thyroid carcinoma.Methods:Within the framework of the present study, the THCA cohort was analyzed in detail based on data obtained from The TCGA database in the context of the EMT. The TCGA-THCA cohort was then divided into two groups, high-and low-risk groups, based on the calculated EMT scores.Finally, based on the findings from the WGCNA algorithm, LASSO regression analysis, and Kaplan-Meier plotter, we selected five genes (CTSK, C3ORF80, FBLN2, PRELP and SRPX2) associated with patient prognosis. Furthermore, this study examined the presence of various immune cells within the THCA samples using three distinct algorithms, ssGSEA, xCell, and MCPcounter. Additional studies have been conducted to establish the roles of CTSK in THCA cell proliferation and migration using various assays, such as CCK8, colony formation, EdU proliferation, Transwell migration and wound healing assays.The involvement of CTSK in the regulation of various EMT-related markers was confirmed using Western blot.Results:Based on EMT scores, TCGA-THCA patients were further divided into two groups, and the study revealed that patients in the high-risk group had a worse prognosis than those in the low-risk group. Among the five genes linked to the prognostic value of EMT (CTSK, C3ORF80, FBLN2, PRELP, and SRPX2), CTSK exhibited notably elevated expression in the high-risk cohort. This group also exhibited pronounced immune cell infiltration, with a marked correlation observed between CTSK expression and the levels of macrophages, MDSCs, and various T-cell subtypes.Furthermore, in vitro studies demonstrated that reducing CTSK expression led to significant reductions in THCA cell viability; clonogenic, proliferative, motility and migratory capacities; and the expression of key EMT-related proteins, including N-cadherin, vimentin, slug, and snail. Conclusion:Our results suggest that the expression of CTSK, a gene associated with the EMT, may be associated with THCA onset and progression and thus may serve as a promising prognostic biomarker.

    Keywords: THCA, EMT, CTSK, Immune infiltration, biomarker

    Received: 11 Jul 2024; Accepted: 16 Oct 2024.

    Copyright: © 2024 Wu, Liu, Zeng, Ruan, Tao, Lin, Liu, Chen, Liu and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Wenrong Lin, Department of Ultrasound, Clinical Oncology School of Fujian Medical University, Fuzhou, China
    Chang Liu, Department of Head and Neck Surgery, Clinical Oncology School of Fujian Medical University & Fujian Cancer Hospital, Fuzhou, China
    Hui Liu, Department of Head and Neck Surgery, Clinical Oncology School of Fujian Medical University & Fujian Cancer Hospital, Fuzhou, China
    Yu Wu, Department of Head and Neck Surgery, Clinical Oncology School of Fujian Medical University & Fujian Cancer Hospital, Fuzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.